Upstream Processing
In the world of upstream development, one wrong move can spell disaster. Consistent, reliable performance is the key to success – and that means choosing a partner who understands your goals, and can supply everything you need from a single, proven source.
With trusted products, in-depth expertise and unrivalled regulatory support, we can help you improve your product’s consistency and bring it to market faster. From high quality chemically-defined cell culture media and feeds to raw materials, special components and customized Cleaning in Place solutions – and, of course, our unique EMPROVE® quality and documentation service – we take you higher.
Cell Culture Media
Quality is nothing without consistency. That’s why we source the raw materials for our chemically defined cell culture media and feeds so carefully, using our proven EMPROVE® quality standard whenever possible, then produce them under cGMP conditions.
Cell Culture Supplements
EMD Millipore’s wide range of animal origin-free and animal-derived cell culture supplements is designed with one aim in mind: To help you grow your success.
Mobius Disposable Manufacturing
Whether you are looking to introduce single-use manufacturing components into your current process or investigating how you can implement a single-use process train, Mobius products and solutions can help you meet your changing manufacturing requirements.
Cleaning in Place
Our tailor-made, top quality Cleaning in Place solutions help you save time, money and effort. Instead of preparing your own solutions, simply order the volumes and concentrations you require from our new GMP process solutions plant – then integrate them into your own cleanroom straight away.
Harvest, Lysis and Purification
FDA guidelines for the manufacture of recombinant biologicals for therapeutic use demand that nucleic acid contamination should be limited per dose in the drug product. Benzonase® endonuclease, when used under appropriate reaction conditions, will degrade all nucleic acid sequences down to oligonucleotides significantly below the hybridization limit, enabling recombinant proteins to meet the FDA guidelines for nucleic acid contamination.
